| scholarly article | Q13442814 |
| P50 | author | Jameel M Inal | Q46581497 |
| P2093 | author name string | Paul R Thompson | |
| Sigrun Lange | |||
| Uchini S Kosgodage | |||
| Rita P Trindade | |||
| P2860 | cites work | Microvesicles: mediators of extracellular communication during cancer progression | Q24628728 |
| Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities | Q26828930 | ||
| Microvesicles released constitutively from prostate cancer cells differ biochemically and functionally to stimulated microvesicles released through sublytic C5b-9. | Q48678700 | ||
| MDR1, MRP1 and LRP expression in patients with untreated acute leukaemia: correlation with 99mTc-MIBI bone marrow scintigraphy. | Q51913491 | ||
| Calpain activation in plasma membrane bleb formation during tert-butyl hydroperoxide-induced rat hepatocyte injury. | Q54021698 | ||
| Inhibition of microparticle release triggers endothelial cell apoptosis and detachment | Q62977653 | ||
| The effects of calpeptin (a calpain specific inhibitor) on agonist induced microparticle formation from the platelet plasma membrane | Q72595390 | ||
| A phase II study of continuous infusion 5-fluorouracil in advanced hormone refractory prostate cancer. An Illinois Cancer Center Study | Q72910588 | ||
| Microvesicle shedding and lysosomal repair fulfill divergent cellular needs during the repair of streptolysin O-induced plasmalemmal damage | Q27320039 | ||
| Microvesicle removal of anticancer drugs contributes to drug resistance in human pancreatic cancer cells | Q28468669 | ||
| Exosome release and low pH belong to a framework of resistance of human melanoma cells to cisplatin | Q28539631 | ||
| Membrane vesicles as conveyors of immune responses | Q29547765 | ||
| Inhibition of microvesiculation sensitizes prostate cancer cells to chemotherapy and reduces docetaxel dose required to limit tumor growth in vivo. | Q30404427 | ||
| Acid sphingomyelinase activity triggers microparticle release from glial cells | Q30486802 | ||
| Massive release of extracellular vesicles from cancer cells after photodynamic treatment or chemotherapy | Q30823413 | ||
| ATP competitive protein kinase C inhibitors demonstrate distinct state-dependent inhibition | Q34063685 | ||
| Differential regulation of AQP2 trafficking in endosomes by microtubules and actin filaments. | Q34437736 | ||
| ABC multidrug transporters: structure, function and role in chemoresistance. | Q34586418 | ||
| Small molecule inhibitors of multidrug resistance gene (MDR1) expression: preclinical evaluation and mechanisms of action | Q34856912 | ||
| ABCA1 gene deletion protects against cerebral malaria: potential pathogenic role of microparticles in neuropathology. | Q35083516 | ||
| Production, fate and pathogenicity of plasma microparticles in murine cerebral malaria | Q35126111 | ||
| Survivin is released from cancer cells via exosomes. | Q35217196 | ||
| Protection against cerebral malaria by the low-molecular-weight thiol pantethine | Q36446215 | ||
| Multidrug resistance: retrospect and prospects in anti-cancer drug treatment. | Q36536479 | ||
| RhoA triggers a specific signaling pathway that generates transforming microvesicles in cancer cells. | Q36713922 | ||
| Search for inhibitors of endocytosis: Intended specificity and unintended consequences | Q36714567 | ||
| Bisindolylmaleimides in anti-cancer therapy - more than PKC inhibitors | Q37219244 | ||
| Microvesicles in health and disease. | Q37981578 | ||
| The role of microvesicles in cancer progression and drug resistance. | Q38077244 | ||
| Blood/plasma secretome and microvesicles | Q38099454 | ||
| The modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decade | Q38305824 | ||
| A novel role for peptidylarginine deiminases in microvesicle release reveals therapeutic potential of PAD inhibition in sensitizing prostate cancer cells to chemotherapy | Q38443364 | ||
| The Emerging Role of Extracellular Vesicle-Mediated Drug Resistance in Cancers: Implications in Advanced Prostate Cancer | Q38639852 | ||
| Microvesicle- and exosome-mediated drug delivery enhances the cytotoxicity of Paclitaxel in autologous prostate cancer cells | Q38833830 | ||
| Nuclear Trapping through Inhibition of Exosomal Export by Indomethacin Increases Cytostatic Efficacy of Doxorubicin and Pixantrone | Q38835369 | ||
| Shikonin selectively induces apoptosis in human prostate cancer cells through the endoplasmic reticulum stress and mitochondrial apoptotic pathway | Q38886603 | ||
| Prostate cancer cells stimulated by calcium-mediated activation of protein kinase C undergo a refractory period before re-releasing calcium-bearing microvesicles. | Q38896507 | ||
| Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery | Q38969541 | ||
| Delivery of chemotherapeutic drugs in tumour cell-derived microparticles. | Q39224333 | ||
| Human plasma membrane-derived vesicles halt proliferation and induce differentiation of THP-1 acute monocytic leukemia cells. | Q39648167 | ||
| Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. | Q40452110 | ||
| Rapid secretion of interleukin-1beta by microvesicle shedding | Q40765816 | ||
| Pantethine Prevents Murine Systemic Sclerosis Through the Inhibition of Microparticle Shedding. | Q42474294 | ||
| Cross-inhibition of SR-BI- and ABCA1-mediated cholesterol transport by the small molecules BLT-4 and glyburide | Q44854863 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | chemotherapy | Q974135 |
| P577 | publication date | 2017-05-09 | |
| P1433 | published in | International Journal of Molecular Sciences | Q3153277 |
| P1476 | title | Chloramidine/Bisindolylmaleimide-I-Mediated Inhibition of Exosome and Microvesicle Release and Enhanced Efficacy of Cancer Chemotherapy | |
| P478 | volume | 18 |
| Q58785789 | Cannabidiol (CBD) Is a Novel Inhibitor for Exosome and Microvesicle (EMV) Release in Cancer |
| Q60929868 | Cannabidiol Affects Extracellular Vesicle Release, miR21 and miR126, and Reduces Prohibitin Protein in Glioblastoma Multiforme Cells |
| Q90267081 | Cannabidiol Is a Novel Modulator of Bacterial Membrane Vesicles |
| Q91685101 | Cyclophosphamide enhances the release of tumor exosomes that elicit a specific immune response in vivo in a murine T-cell lymphoma |
| Q92577974 | Exosomal miR-16-5p as a target for malignant mesothelioma |
| Q55342189 | Extracellular Vesicles in Prostate Cancer Carcinogenesis, Diagnosis, and Management. |
| Q47622685 | Extracellular vesicles as emerging targets in cancer: Recent development from bench to bedside |
| Q64100363 | Extracellular vesicles-mediated intercellular communication: roles in the tumor microenvironment and anti-cancer drug resistance |
| Q89456981 | Inhibiting extracellular vesicles formation and release: a review of EV inhibitors |
| Q64056707 | Intercellular Vesicular Transfer by Exosomes, Microparticles and Oncosomes - Implications for Cancer Biology and Treatments |
| Q91975119 | Peptidylarginine Deiminase Inhibitors Reduce Bacterial Membrane Vesicle Release and Sensitize Bacteria to Antibiotic Treatment |
| Q89879539 | Peptidylarginine Deiminase Isozyme-Specific PAD2, PAD3 and PAD4 Inhibitors Differentially Modulate Extracellular Vesicle Signatures and Cell Invasion in Two Glioblastoma Multiforme Cell Lines |
| Q60927782 | Peptidylarginine Deiminases Post-Translationally Deiminate Prohibitin and Modulate Extracellular Vesicle Release and MicroRNAs in Glioblastoma Multiforme |
| Q39354673 | Peptidylarginine Deiminases-Roles in Cancer and Neurodegeneration and Possible Avenues for Therapeutic Intervention via Modulation of Exosome and Microvesicle (EMV) Release? |
| Q89456970 | Plasma mEV levels in Ghanain malaria patients with low parasitaemia are higher than those of healthy controls, raising the potential for parasite markers in mEVs as diagnostic targets |
| Q93185541 | Post-Translational Protein Deimination Signatures in Serum and Serum-Extracellular Vesicles of Bos taurus Reveal Immune, Anti-Pathogenic, Anti-Viral, Metabolic and Cancer-Related Pathways for Deimination |
| Q92634066 | Protein Deimination and Extracellular Vesicle Profiles in Antarctic Seabirds |
| Q53706571 | The biology of extracellular microvesicles. |
| Q104617792 | The roles of exosomes in cancer drug resistance and its therapeutic application |
| Q64234727 | Thioredoxin Modulates Protein Arginine Deiminase 4 (PAD4)-Catalyzed Citrullination |
Search more.